Search results for "COVID-19"
Latest data on COVID-19's potential treatments, effects on drug abuse and mortality
A living systematic review still only finds strong support for steroids, an antibody cocktail reduced viral load in outpatients, overdoses rose during lockdowns, and studies looked at loss of life from the pandemic.
https://immattersacp.org/weekly/archives/2020/12/22/2.htm
22 Dec 2020
Anaphylaxis appears rare with COVID-19 vaccine, alternative administration strategies considered
The CDC's monitoring system found low rates of anaphylaxis after a first dose of the Pfizer-BioNTech COVID-19 vaccine, peer-reviewed data were published on the Moderna vaccine, and alternate vaccine administration strategies were evaluated.
https://immattersacp.org/weekly/archives/2021/01/12/2.htm
12 Jan 2021
New research analyzes COVID-19 outcomes, testing, and experimental treatments
A retrospective report looked at serologic antibody testing, while two case series reports described use of convalescent plasma in critically ill patients with COVID-19 in China.
https://immattersacp.org/weekly/archives/2020/04/07/2.htm
7 Apr 2020
New research looks at COVID-19 quarantine length in asymptomatic contacts, convalescent plasma for mild disease, related health issues
Seven-day quarantine may be sufficient for contacts without symptoms, older adults with mild disease may benefit from convalescent plasma, and cardiovascular deaths increased during the early stage of the pandemic.
https://immattersacp.org/weekly/archives/2021/01/12/3.htm
12 Jan 2021
Mixed findings on remdesivir for COVID-19, news on SARS-CoV-2 vaccines
Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
https://immattersacp.org/weekly/archives/2020/10/20/2.htm
20 Oct 2020
Risk of re-infection, benefits of anticoagulation, cause of sex differences among COVID-19 research
Researchers published evidence of re-infection with SARS-CoV-2, anticoagulation was associated with halved inpatient mortality, recommendations were made on pulmonary embolism in COVID-19, and a study attributed differences in men's and women's outcomes to T cells.
https://immattersacp.org/weekly/archives/2020/09/01/2.htm
1 Sep 2020
COVID-19 vaccine protection, primary care delays and international differences during the pandemic
An analysis of the omicron surge found that unvaccinated people were 23 times more likely to be hospitalized than those who got a booster. Two studies assessed how the pandemic delayed primary care, and an international study tied lower infection rates to trust in government.
https://immattersacp.org/weekly/archives/2022/02/08/1.htm
8 Feb 2022
Intensive food-as-medicine program improves engagement, not glycemic control
Patients with diabetes and food insecurity who received healthy groceries, dietitian consults, nurse evaluations, health coaching, and diabetes education had increased engagement with preventive care but no significant change in HbA1c levels versus usual care.
https://immattersacp.org/weekly/archives/2024/01/02/2.htm
2 Jan 2024
New research on Pfizer pill, mental disorders after COVID-19, vaccine reactions
A manufacturer-funded trial quantified the effectiveness of nirmatrelvir/ritonavir in outpatients. A retrospective study found veterans had more mental health diagnoses and received more antidepressants, benzodiazepines, and opioids after COVID-19, while two other studies looked at reactions to second and third doses of the vaccines.
https://immattersacp.org/weekly/archives/2022/02/22/1.htm
22 Feb 2022
New research on PASC, COVID-19 infection and vaccination during pregnancy
Two studies analyzed postacute sequelae of COVID-19 (PASC) in older and ICU patients. Other new research showed that symptomatic infection during delivery raised risks in pregnant women but vaccination during pregnancy was safe. An ACP/Annals of Internal Medicine forum focused on outpatient management of COVID-19, and the FDA issued an emergency use authorization for a new monoclonal antibody treatment.
https://immattersacp.org/weekly/archives/2022/02/15/1.htm
15 Feb 2022